Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NEOCERA Advanced Barrier Cream

K-Number: K170911 · 2017-08-22

ApplicantExeltis USA Dermatology, LLC
Decision Date2017-08-22
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

NEOCERA Advanced Barrier Cream is the device name listed in this FDA 510(k) record. The listed applicant is Exeltis USA Dermatology, LLC. It received FDA 510(k) clearance on 2017-08-22 under 510(k) number K170911. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NEOCERA Advanced Barrier Cream?

NEOCERA Advanced Barrier Cream is a medical device that received FDA 510(k) clearance on 2017-08-22. The listed applicant is Exeltis USA Dermatology, LLC. The 510(k) number is K170911.

When did NEOCERA Advanced Barrier Cream receive FDA 510(k) clearance?

NEOCERA Advanced Barrier Cream received FDA 510(k) clearance on 2017-08-22, under 510(k) number K170911.

Who is the listed applicant for NEOCERA Advanced Barrier Cream?

The FDA 510(k) record lists Exeltis USA Dermatology, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NEOCERA Advanced Barrier Cream?

The FDA product code for NEOCERA Advanced Barrier Cream is FRO. This falls under the Anesthesiology category.

Related Devices (Code: FRO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261646Redermax® Antibacterial Wound MatrixBeijing Kreate Medical Co., Ltd.K253665Vashe Plus Antimicrobial SolutionUrgo Medical North America, LLCK261023Microdacyn Wound Irrigation SolutionSonoma Pharmaceuticals, Inc.K251929SilverCeuticals® Antimicrobial Wound GelSilverceuticals, Inc.K261638Bonvadis®Oneness Biotech Co., Ltd.K254073StatSeal DiscMerit Medical Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑